23andMe CEO happy to be back in business, looking toward the future
23andMe can finally take a deep breath and move forward following FDA approval, and CEO Anne Wojcicki is doing just that.
Did Elizabeth Holmes take away too much power from Theranos shareholders? (Update)
Elizabeth Holmes has an extreme amount of control over the future of Theranos, maybe more than some shareholders even realized.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Theranos will “absolutely” get FDA approval and does not need more capital
Elizabeth Holmes has no doubt that Theranos will continue moving forward, despite public criticism.
FDA: Theranos peddling “uncleared medical devices”
More scrutiny for Theranos: Two FDA reports have found that Theranos' much-touted nanotainers are actually "uncleared medical devices" that are wrongfully shipped across state lines.
Theranos: We’ll start publishing our data
Stay tuned for what kind and form that data comes in.
An Arizona doctor’s perspective on Theranos
Theranos is dealing with more push-back as its finger-stick blood-testing method gets put on hold at Walgreens locations before the FDA gives a final OK.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
A look at the underbelly of Theranos, plus 5 must-read stories from MedCity News this week
A look back at the week that was in the business of healthcare: Theranos' reputation post-Wall Street Journal exposé, and the ROIs of genetic testing.
Morning Read: Theranos scales back use of fingerprick test vials, Bernie Sanders says no to Shkreli money
Theranos founder Elizabeth Holmes has moved to limit its fingerprick blood test vials after being forced on the defensive over its technology claims.
Theranos seems to be significantly exaggerating the capabilities of its diagnostic device
With just a few drops of blood, 240 tests can be processed. Or maybe closer to 15 for now because Theranos is really just on "a journey" toward actually doing what it says it can do.
FDA makes it easier for Theranos to conduct testing outside of certified labs
Palo Alto super-startup Theranos got the OK from the FDA for its HSV-1 test to be performed outside of CLIA-certified labs - an important cog in its marketing strategy.
Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Theranos gets first FDA clearance, emerges from secrecy
Theranos, the secretive Palo Alto diagnostics company, just received regulatory approval for its HSV-1 test - a sign that perhaps it'll start chasing further approvals.
Occam’s razor and the secrecy of Theranos – a.k.a., is it all a bunch of crock? No.
Ever look at a piece of modern art and think, “Damn! I could have painted that.” Yet, it’s hanging in the Getty and your ear’s still intact. Let’s take that idea, and extrapolate it to the secretive megastartup Theranos – and whether, underneath all this mystery, it’s actually a bunch of crock. Here’s my wager: It’s […]
Best of 2014: Theranos secretive lab test startup
MedCity News has checked out the data and put together a list of which stories got the most online traffic on the site in 2014 – which demonstrates some trends and what readers really wanted to know more about. As the year wraps up, we are re-sharing some of the stories that had a substantial […]
Theranos CEO wants to make blood tests less painful and easier to get (video)
Theranos CEO Elizabeth Holmes' appearance at TEDMED 2014 this week drew a lot of attention as the company prepares with Walgreens to roll out physician-ordered diagnostic test collection centers at stores around the country.